Stefan Verlohren

Stefan Verlohren

UNVERIFIED PROFILE

Are you Stefan Verlohren?   Register this Author

Register author
Stefan Verlohren

Stefan Verlohren

Publications by authors named "Stefan Verlohren"

Are you Stefan Verlohren?   Register this Author

43Publications

897Reads

49Profile Views

Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia.

Hypertension 2020 Jan 2;75(1):202-210. Epub 2019 Dec 2.

From the Experimental and Clinical Research Center-a joint cooperation between the Max Delbrück Center for Molecular Medicine and the Charité-Universitätsmedizin Berlin, Germany (K.K., F.H., M.G., S.G., A.B., D.N.M., R.D., N.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13219DOI Listing
January 2020

Kagami-Ogata syndrome: an important differential diagnosis to Beckwith-Wiedemann syndrome.

J Clin Ultrasound 2020 Jan 28. Epub 2020 Jan 28.

Klinik für Geburtsmedizin, Charité - Universitätsmedizin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.22815DOI Listing
January 2020

Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/ PlGF Ratio in Singleton Pregnancies.

Fetal Diagn Ther 2018 19;43(2):81-89. Epub 2017 Jul 19.

Fetal Medicine Unit, Maternal and Child Health and Development Network (SAMID-RD12/0026/0016), Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Department of Obstetrics and Gynecology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000477903DOI Listing
August 2018

Author's reply re: Pre-eclampsia is primarily a placental disorder: FOR: Pre-eclampsia is primarily a placental disorder.

Authors:
Stefan Verlohren

BJOG 2018 03 14;125(4):513-514. Epub 2017 Dec 14.

Department of Obstetrics, Charite - Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1471-0528.15010DOI Listing
March 2018

Pre-eclampsia is primarily a placental disorder: FOR: Pre-eclampsia is primarily a placental disorder.

Authors:
Stefan Verlohren

BJOG 2017 Oct;124(11):1762

Charité, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1471-0528.14615DOI Listing
October 2017

Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.

Hypertension 2017 06 1;69(6):1192-1197. Epub 2017 May 1.

From the Departments of Obstetrics (S.V., L.A.D., W.H.) and Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry (F.H.P.), Charité Universitätsmedizin Berlin, Germany; Labor Berlin - Charité Vivantes GmbH, Germany (F.H.P.); Fetal Medicine Unit, St Georges University Hospital Foundation NHS Trust and St Georges University London, UK (B.T., A.K.); and HealthTwiSt GmbH, Berlin, Germany (A.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09256DOI Listing
June 2017

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.

Hypertens Pregnancy 2017 May 11;36(2):175-185. Epub 2017 May 11.

a Department of Obstetrics , Campus Virchow-Clinic, Charite´ University Medicine , Berlin , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10641955.2017.1291673DOI Listing
May 2017

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.

Hypertens Pregnancy 2017 May 10;36(2):151-160. Epub 2017 Feb 10.

a Department of Obstetrics , Charité University Medicine , Berlin , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10641955.2016.1273363DOI Listing
May 2017

Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.

Pregnancy Hypertens 2017 Apr 1;8:31-36. Epub 2017 Mar 1.

Department of Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry, Charité Universitätsmedizin Berlin, Germany; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.preghy.2017.02.005DOI Listing
April 2017

Natural Killer Cell Reduction and Uteroplacental Vasculopathy.

Hypertension 2016 10 22;68(4):964-73. Epub 2016 Aug 22.

From the Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Germany (M.G., N.H., F.H., A.W., A.B., F.C.L., L.P., D.N.M., R.D.); Department of Obstetrics (M.G., S.V., W.H.) and Department of Gynecology (M.G.), Charité - Universitätsmedizin Berlin, Germany; Berlin Institute of Health (BIH), Germany (M.G., N.H., F.H., A.W., A.B., F.C.L., L.P., S.V., D.N.M., R.D.); Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (N.H., F.H., A.B., D.N.M.); Charité - Universitätsmedizin Berlin, Campus Berlin Buch, Germany (A.W., F.C.L., L.P., R.D.); Department of Development and Regeneration, University Hospital Leuven, Belgium (L.V., R.P.); Department of Medical Biology, János Szentágothai Research Centre Pécs, University of Pécs Medical School, Hungary (A.B.); Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Norway (P.C.S., E.D.); Department of Multi-Disciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Lørenskog, Norway (P.C.S.); Clinic for Nephrology and Hypertension, Hannover Medical School, Germany (J.-K.P.); University of Oslo, Norway (P.A.-K., A.C.S.); Department of Obstetrics and Gynecology, Oslo University Hospital, Norway (P.A.-K., A.C.S.); and Department of Cardiology and Nephrology, HELIOS Klinikum Berlin, Germany (R.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07800DOI Listing
October 2016

Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia.

Obstet Gynecol 2016 08;128(2):261-9

Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria; the Department of Obstetrics, Maternal-Fetal Medicine Unit, Hospital Universitari Vall d'Hebron, and the Maternal and Child Health and Development Network (SAMID) RD12/0026, Instituto de Salud Carlos III, Barcelona, Spain; the Department of Obstetrics and Gynecology, University of Liege, CHR de la Citadelle, Liege, Belgium; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom (previously University Hospitals National Health Service Trust, Coventry, United Kingdom, during the conduct of the study); the Departments of Gynecology and Obstetrics, Oslo University Hospital and University of Oslo, Oslo, Norway; the Department of Women's and Children's Health, Karolinska University Hospital, Karolinska Institute, Stockholm, and the Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden; the Pregnancy Research Centre, Department of Maternal-Fetal Medicine, Royal Women's Hospital and Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia; the Department of Obstetrics, University of Leipzig, Leipzig, Roche Diagnostics GmbH, Penzberg, and the Department of Obstetrics, Charité Universitätsmedizin, Berlin, Germany; and Roche Diagnostics International, Rotkreuz, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000001525DOI Listing
August 2016

The sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

N Engl J Med 2016 05;374(18):1785-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1602338DOI Listing
May 2016

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

N Engl J Med 2016 Jan;374(1):13-22

From the Department of Obstetrics and Gynecology, Medical University Vienna, Vienna (H.Z.); the Department of Obstetrics, Maternal-Fetal Medicine Unit, Hospital Universitari Vall d'Hebron, Barcelona, and the Maternal and Child Health and Development Network, Instituto de Salud Carlos III, Madrid (E.L.); the Department of Obstetrics and Gynecology, University of Liege, Liege, Belgium (F.C.); Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom (M.V.); the Departments of Gynecology and Obstetrics, Oslo University Hospital, and University of Oslo, Oslo (A.C.S.); the Department of Women's and Children's Health, Karolinska University Hospital, and Karolinska Institute, Stockholm (M. Sennström), and the Department of Women's and Children's Health, Uppsala University, Uppsala (M.O.) - both in Sweden; Pregnancy Research Centre, Department of Perinatal Medicine, Royal Women's Hospital and Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia (S.P.B.); the Department of Obstetrics, University of Leipzig, Leipzig (H.S.), Roche Diagnostics, Penzberg (P.D., M. Schoedl), and the Department of Obstetrics, Campus Virchow-Klinikum Charité, Berlin (S.V.) - all in Germany; and Roche Diagnostics International, Rotkreuz, Switzerland (D.A., M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1414838DOI Listing
January 2016

Update on the pathophysiological implications and clinical role of angiogenic factors in pregnancy.

Fetal Diagn Ther 2015 3;37(2):81-92. Epub 2015 Feb 3.

Department of Obstetrics, Maternal-Foetal Medicine Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000368605DOI Listing
November 2015

Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia.

Prenat Diagn 2015 Apr 4;35(4):386-93. Epub 2015 Feb 4.

Department of Pathology and Laboratory Medicine, Women & Infants Hospital/Alpert Medical School at Brown University, Providence, RI, USA; Savjani Institute for Health Research, Windham, ME, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pd.4554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409832PMC
April 2015

Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction.

Obstet Gynecol 2014 Aug;124(2 Pt 1):265-73

Fetal Medicine Unit-SAMID, Department of Obstetrics and Gynaecology, Hospital Universitario 12 de Octubre, Madrid, Spain; and the Department of Obstetrics, Charité University Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/greenjournal/2014/08000/Charact
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/AOG.0000000000000367DOI Listing
August 2014

Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.

Hypertens Pregnancy 2013 Nov 19;32(4):459-73. Epub 2013 Aug 19.

Department of Obstetrics, Charité University Medicine , Berlin , Germany .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10641955.2013.827205DOI Listing
November 2013

Antiangiogenic factors and maternal hemodynamics during intensive hemodialysis in pregnancy.

Hemodial Int 2013 Oct 1;17(4):639-43. Epub 2013 Apr 1.

Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/hdi.12042
Publisher Site
http://dx.doi.org/10.1111/hdi.12042DOI Listing
October 2013

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

Hypertens Pregnancy 2013 May;32(2):189-201

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10641955.2013.784788DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744824PMC
May 2013

Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.

Hypertension 2012 Aug 2;60(2):451-8. Epub 2012 Jul 2.

Division of Maternal Fetal Medicine/Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Kirstein 382, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.195065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432569PMC
August 2012

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.

Circulation 2012 Feb 18;125(7):911-9. Epub 2012 Jan 18.

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Kirstein 382, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.054361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319742PMC
February 2012

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.

Clin Sci (Lond) 2012 Jan;122(2):43-52

Department of Obstetrics, Campus Virchow Clinic, Charité University Medicine Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20110097DOI Listing
January 2012

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.

Am J Obstet Gynecol 2010 Feb 21;202(2):161.e1-161.e11. Epub 2009 Oct 21.

Department of Obstetrics, Campus Virchow-Clinic, Charité University Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2009.09.016DOI Listing
February 2010

Immunology in hypertension, preeclampsia, and target-organ damage.

Hypertension 2009 Sep 13;54(3):439-43. Epub 2009 Jul 13.

HELIOS Cinic, Franz-Volhard Clinic, Experimental and Clinical Research Center, Wiltbergstrasse 50, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.120253DOI Listing
September 2009

Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.

Hypertension 2009 Feb 8;53(2):393-8. Epub 2008 Dec 8.

Medical Faculty of the Charité, Franz-Volhard Clinic, HELIOS Klinikum Berlin-Buch and Experimental and Clinical Research Center, Berlin, Germany.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.108.
Publisher Site
http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.124115DOI Listing
February 2009

Trophoblasts reduce the vascular smooth muscle cell proatherogenic response.

Hypertension 2008 Feb 14;51(2):554-9. Epub 2008 Jan 14.

Experimental and Clinical Research Center, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.102905DOI Listing
February 2008

Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries.

Hypertension 2004 Sep 9;44(3):271-6. Epub 2004 Aug 9.

Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine, Charité University Hospitals, Humboldt University of Berlin, HELIOS Klinikum Berlin, Germany.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/01.HYP.0000140058.28
Publisher Site
http://dx.doi.org/10.1161/01.HYP.0000140058.28994.ecDOI Listing
September 2004

Mechanisms of ADRF release from rat aortic adventitial adipose tissue.

Am J Physiol Heart Circ Physiol 2004 Mar 26;286(3):H1107-13. Epub 2003 Nov 26.

Franz Volhard Clinic, Wiltbergstrasse 50, 13125 Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.physiology.org/doi/10.1152/ajpheart.00656.2003
Publisher Site
http://dx.doi.org/10.1152/ajpheart.00656.2003DOI Listing
March 2004